In recent years, clinicians and patients alike have taken interest in how certain therapies originally intended for other indications may also influence body mass. Among them, the SGLT2 inhibitor has ...
In recent years, clinicians and patients alike have taken interest in how certain therapies originally intended for other indications may also influence body mass. Among them, the SGLT2 inhibitor has ...